[Evaluation of drug interactions in patients treated for a lung or digestive cancer].

CONCLUSION: Drug interactions remain a major concern in cancer hospitalized patients. It is important to continue and strengthen the collaboration between physicians and pharmacists in order to better prevent their occurrence. PMID: 33012503 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33012503?dopt=Abstract

Source: Bulletin du Cancer - September 30, 2020 Category: Cancer & Oncology Authors: Ghysel V, Tresch E, Marliot G, Nicot R, Lambert M, Carbonnelle G, Lartigau E, Lefebvre G Tags: Bull Cancer Source Type: research